Co-Diagnostics Inc
NASDAQ:CODX

Watchlist Manager
Co-Diagnostics Inc Logo
Co-Diagnostics Inc
NASDAQ:CODX
Watchlist
Price: 1.24 USD 2.48%
Market Cap: 39.6m USD
Have any thoughts about
Co-Diagnostics Inc?
Write Note

Co-Diagnostics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Co-Diagnostics Inc
Total Equity Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Co-Diagnostics Inc
NASDAQ:CODX
Total Equity
$72.4m
CAGR 3-Years
-6%
CAGR 5-Years
72%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Total Equity
$25.9B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
17%
Boston Scientific Corp
NYSE:BSX
Total Equity
$20.7B
CAGR 3-Years
8%
CAGR 5-Years
16%
CAGR 10-Years
12%
Stryker Corp
NYSE:SYK
Total Equity
$20.1B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Total Equity
$39.3B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Equity
$15.6B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
18%

See Also

What is Co-Diagnostics Inc's Total Equity?
Total Equity
72.4m USD

Based on the financial report for Jun 30, 2024, Co-Diagnostics Inc's Total Equity amounts to 72.4m USD.

What is Co-Diagnostics Inc's Total Equity growth rate?
Total Equity CAGR 5Y
72%

Over the last year, the Total Equity growth was -30%. The average annual Total Equity growth rates for Co-Diagnostics Inc have been -6% over the past three years , 72% over the past five years .

Back to Top